Understanding the Interaction Between Ataxin-2 and TDP-43 in Neurons for ALS Treatment
Author Information
Author(s): Tian Yuan, Heinsinger Nicolette, Hu Yinghui, Lim U-Ming, Wang Yi, Fernandis Aaron Zefrin, Parmentier-Batteur Sophie, Klein Becky, Uslaner Jason M., Smith Sean M.
Primary Institution: Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey, United States of America
Hypothesis
The interaction between Ataxin-2 and TDP-43 may provide insights into potential therapeutic targets for ALS.
Conclusion
This study identifies the Ataxin-2 and TDP-43 interactome and suggests potential therapeutic pathways to alleviate TDP-43 toxicity in ALS.
Supporting Evidence
- Ataxin-2 and TDP-43 interact in both iPSC-derived neurons and mouse brain tissue.
- Knocking down Ataxin-2 alleviates TDP-43-induced neuronal loss and stress granule formation.
- The interaction between Ataxin-2 and TDP-43 is mediated through the RNA recognition motif of TDP-43.
Takeaway
Scientists studied two proteins, Ataxin-2 and TDP-43, to see how they work together in brain cells and how this might help treat a disease called ALS.
Methodology
The study used co-immunoprecipitation and mass spectrometry to analyze the interaction between Ataxin-2 and TDP-43 in iPSC-derived neurons.
Limitations
The study does not directly demonstrate that the interaction between Ataxin-2 and TDP-43 is mediated by RNA.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website